PMID: 9721099Aug 28, 1998

Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats

Science
B Moghaddam, B W Adams

Abstract

Glutamatergic abnormalities have been associated with several psychiatric disorders, including schizophrenia and addiction. Group II metabotropic glutamate receptors were targeted to normalize glutamatergic disruptions associated with an animal model of schizophrenia, the phencyclidine model. An agonist of this group of receptors, at a dose that was without effects on spontaneous activity and corticolimbic dopamine neurotransmission, attenuated the disruptive effects of phencyclidine on working memory, stereotypy, locomotion, and cortical glutamate efflux. This behavioral reversal occurred in spite of sustained dopamine hyperactivity. Thus, targeting this group of receptors may present a nondopaminergic therapeutic strategy for treatment of psychiatric disorders.

References

Apr 29, 1999·Journal of Neuroscience Research·C WangK M Johnson
Aug 6, 1999·Journal of Clinical Pharmacology·M E Schmidt
Aug 27, 2009·Cellular and Molecular Life Sciences : CMLS·José L MorenoJavier González-Maeso
Jan 17, 2007·Psychopharmacology·Younglim LeeAnantha Shekhar
May 29, 2009·Psychopharmacology·P R CorlettP C Fletcher
May 17, 2012·Psychopharmacology·Emily L NewmanKlaus A Miczek
Sep 29, 2007·European Archives of Psychiatry and Clinical Neuroscience·Seong S ShimBaik S Kee
Aug 15, 2013·Cell and Tissue Research·Vincenzo MicaleAlexandra Sulcova
Feb 28, 2008·Journal of Neural Transmission·L WatisK Sim
Jan 25, 2007·Amino Acids·A Pilc, K Ossowska
Jul 10, 2009·Bulletin of Mathematical Biology·Hamid Reza Noori, Willi Jäger
Dec 21, 2000·Current Psychiatry Reports·D C Javitt
Jun 23, 2004·Biology of the Cell·J-P PinL Prézeau
Jan 8, 2004·Brain Research Bulletin·German TorresJudith M Horowitz
Mar 17, 2004·Current Opinion in Pharmacology·Gerard J Marek
Dec 27, 2008·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Dennis H KimStephen M Stahl
Feb 24, 2006·NeuroRx : the Journal of the American Society for Experimental NeuroTherapeutics·Giuseppe Blasi, Alessandro Bertolino
Feb 24, 2006·NeuroRx : the Journal of the American Society for Experimental NeuroTherapeutics·Asher B Simon, Jack M Gorman
Dec 4, 2003·Progress in Neuro-psychopharmacology & Biological Psychiatry·Uriel Heresco-Levy

Related Concepts

Prefrontal Cortex
Schizophrenia
Phencyclidine Hydrobromide
Receptors, Metabotropic Glutamate
Fetishism (Psychiatric)
Synaptic Transmission
Bicyclo Compounds
Locomotion
Structure of Cortex of Kidney
Metabotropic glutamate receptor 2

Related Feeds

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.